Pharmacological inhibition of PIM1 suppresses tumor progression and enhances chemosensitivity in hepatocellular carcinoma

被引：0
|
作者：
Leung, Ming Sum [1 ]
Chan, Kwan Shuen [1 ]
Lo, Cheuk Lam [1 ]
机构：
[1] Univ Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)30719-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-472
引用
收藏
页码：E368 / E368
页数：1
相关论文
共 50 条
  • [1] PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma
    Leung, Carmen Oi-ning
    Wong, Carmen Chak-lui
    Fan, Dorothy Ngo-yin
    Kai, Alan Ka-lun
    Tung, Edmund Kwok-kwan
    Xu, Iris Ming-jing
    Ng, Irene Oi-lin
    Lo, Regina Cheuk-lam
    [J]. ONCOTARGET, 2015, 6 (13) : 10880 - 10892
  • [2] Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinoma
    Tam, Ka Ho
    Yang, Zhen Fan
    Lau, Chi Keung
    Lam, Chi Tat
    Pang, Roberta W. C.
    Poon, Ronnie T. P.
    [J]. CANCER LETTERS, 2009, 273 (02) : 201 - 209
  • [3] RETRACTED: Downregulation of PIM1 regulates glycolysis and suppresses tumor progression in gallbladder cancer (Retracted Article)
    Xue, Chen
    He, Yuting
    Hu, Qiuyue
    Yu, Yan
    Chen, Xiaolong
    Chen, Jianan
    Ren, Fang
    Li, Juan
    Ren, Zhigang
    Cui, Guangying
    Sun, Ranran
    [J]. CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 5101 - 5112
  • [4] miRNA-370 acts as a tumor suppressor via the downregulation of PIM1 in hepatocellular carcinoma
    Pan, X. -P.
    Wang, H. -X.
    Tong, D. -M.
    Li, Y.
    Huang, L. -H.
    Wang, C.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (06) : 1254 - 1262
  • [5] Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellular carcinoma
    Dong, Renshun
    Wang, Tianci
    Dong, Wei
    Zhu, He
    Liu, Qiumeng
    Liang, Huifang
    Chen, Xiaoping
    Zhang, Bixiang
    Zhang, Xuewu
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
  • [6] Arsenic trioxide-induced upregulation of miR-1294 suppresses tumor growth in hepatocellular carcinoma by targeting TEAD1 and PIM1
    Cai, Xiaoniao
    Yu, Leilei
    Chen, Zhen
    Ye, Fangpeng
    Ren, Zonghai
    Jin, Peisheng
    [J]. CANCER BIOMARKERS, 2020, 28 (02) : 221 - 230
  • [7] RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma
    Cheng, Alfred S. L.
    Wong, Nathalie
    Tse, Ada M. Y.
    Chan, Kathy Y. Y.
    Chan, Kai K.
    Sung, Joseph J. Y.
    Chan, Henry L. Y.
    [J]. CANCER LETTERS, 2007, 253 (01) : 43 - 52
  • [8] PIM1 Inhibition Enhances and Prolongs Plerixafor-Induced Mobilization of HSCs
    Mueller, Tony Andreas
    Zwick, Anabel
    Decker, Sarah
    Klein, Claudius
    Rister, Benjamin
    Rudorf, Alina
    Kissel, Sandra
    Follo, Marie
    Waesch, Ralph
    Illert, Anna Lena
    Waskow, Claudia
    Dierks, Christine
    Duyster, Justus
    [J]. BLOOD, 2016, 128 (22)
  • [9] Knockdown of survivin gene suppresses the tumorigenicity and enhances chemosensitivity in hepatocellular carcinoma (HCC)
    Or, Yvonne
    Yang, Zhen
    Xiong, Yue
    Sun, Hui
    Tang, Zhao
    Poon, Ronnie
    [J]. CANCER RESEARCH, 2009, 69
  • [10] siRNA-mediated inhibition of hTERT enhances chemosensitivity of hepatocellular carcinoma
    Guo, Xianling
    Wang, Weifen
    Zhou, Feiguo
    Lu, Zhenghua
    Fang, Ruifang
    Jia, Fengqi
    Bu, Xinxin
    Li, Rong
    Zhang, Baihe
    Wu, Mengchao
    Wei, Lixin
    [J]. CANCER BIOLOGY & THERAPY, 2008, 7 (10) : 1555 - 1560
12345